Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001594864-17-000022
Filing Date
2017-05-04
Accepted
2017-05-04 17:07:37
Documents
65
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q juno-03312017x10q.htm 10-Q 1234694
2 EXHIBIT 10.1 ex-101x0331201710q.htm EX-10.1 29918
3 EXHIBIT 10.2A ex-102ax0331201710q.htm EX-10.2A 39240
4 EXHIBIT 10.2B ex-102bx0331201710q.htm EX-10.2B 29265
5 EXHIBIT 31.1 ex-311x0331201710q.htm EX-31.1 12902
6 EXHIBIT 31.2 ex-312x0331201710q.htm EX-31.2 12372
7 EXHIBIT 32.1 ex-321x0331201710q.htm EX-32.1 7396
8 EXHIBIT 32.2 ex-322x0331201710q.htm EX-32.2 7398
  Complete submission text file 0001594864-17-000022.txt   5725616

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT juno-20170331.xml EX-101.INS 1248130
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT juno-20170331.xsd EX-101.SCH 38700
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT juno-20170331_cal.xml EX-101.CAL 65625
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT juno-20170331_def.xml EX-101.DEF 195088
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT juno-20170331_lab.xml EX-101.LAB 487875
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT juno-20170331_pre.xml EX-101.PRE 318504
Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Filer) CIK: 0001594864 (see all company filings)

EIN.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36781 | Film No.: 17815031
SIC: 2836 Biological Products, (No Diagnostic Substances)